Immix Biopharma Inc (IMMX) — Defensive Interval Ratio
Immix Biopharma Inc (IMMX) has a Defensive Interval Ratio of 260 days as of June 2026. Defensive assets of $6.62 Million (cash $-, short-term investments $6.62 Million, receivables $-) cover 260 days of daily cash needs of $25.48K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Immix Biopharma Inc Defensive Interval Ratio (2019–2025)
This chart shows how Immix Biopharma Inc's Defensive Interval Ratio has evolved across 7 annual periods from 2019 to 2025. As of June 2026, the ratio stands at 260 days, meaning defensive assets of $6.62 Million can fund 260 days of operations without new revenue. For the complete balance sheet picture, see Immix Biopharma Inc balance sheet assets.
Annual Defensive Interval Ratio for Immix Biopharma Inc (2019–2025)
The table below presents the year-by-year Defensive Interval Ratio for Immix Biopharma Inc from 2019 to 2025, covering 7 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See Immix Biopharma Inc (IMMX) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 234 days | $6.48 Million | $27.70K/day | $- | $6.48 Million | ▲ +151 days |
| 2024 | 83 days | $1.97 Million | $23.80K/day | $- | $0.00 | ▼ -32 days |
| 2023 | 115 days | $1.17 Million | $10.20K/day | $- | $- | ▲ +42 days |
| 2022 | 73 days | $255.71K | $3.49K/day | $- | $- | ▲ +27 days |
| 2021 | 46 days | $25.72K | $553.53/day | $- | $- | ▲ +38 days |
| 2020 | 9 days | $127.44K | $14.44K/day | $- | $- | ▼ -5 days |
| 2019 | 14 days | $175.75K | $12.57K/day | $- | $- | — |